FOLD
Price
$9.81
Change
+$0.08 (+0.82%)
Updated
Dec 20, 04:59 PM (EDT)
65 days until earnings call
RCKT
Price
$11.56
Change
+$0.21 (+1.85%)
Updated
Dec 20 closing price
73 days until earnings call
Ad is loading...

FOLD vs RCKT

Header iconFOLD vs RCKT Comparison
Open Charts FOLD vs RCKTBanner chart's image
Amicus Therapeutics
Price$9.81
Change+$0.08 (+0.82%)
Volume$50.75K
CapitalizationN/A
Rocket Pharmaceuticals
Price$11.56
Change+$0.21 (+1.85%)
Volume$2.87M
CapitalizationN/A
FOLD vs RCKT Comparison Chart
Loading...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FOLD vs. RCKT commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FOLD is a Hold and RCKT is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (FOLD: $9.80 vs. RCKT: $11.56)
Brand notoriety: FOLD and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FOLD: 146% vs. RCKT: 265%
Market capitalization -- FOLD: $2.93B vs. RCKT: $1.23B
FOLD [@Biotechnology] is valued at $2.93B. RCKT’s [@Biotechnology] market capitalization is $1.23B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FOLD’s FA Score shows that 0 FA rating(s) are green whileRCKT’s FA Score has 0 green FA rating(s).

  • FOLD’s FA Score: 0 green, 5 red.
  • RCKT’s FA Score: 0 green, 5 red.
According to our system of comparison, RCKT is a better buy in the long-term than FOLD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FOLD’s TA Score shows that 5 TA indicator(s) are bullish while RCKT’s TA Score has 4 bullish TA indicator(s).

  • FOLD’s TA Score: 5 bullish, 4 bearish.
  • RCKT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, FOLD is a better buy in the short-term than RCKT.

Price Growth

FOLD (@Biotechnology) experienced а +4.70% price change this week, while RCKT (@Biotechnology) price change was -3.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

FOLD is expected to report earnings on Feb 26, 2025.

RCKT is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FOLD($2.93B) has a higher market cap than RCKT($1.23B). FOLD YTD gains are higher at: -30.937 vs. RCKT (-61.428). FOLD has higher annual earnings (EBITDA): -9.2M vs. RCKT (-247.25M). FOLD has more cash in the bank: 250M vs. RCKT (236M). RCKT has less debt than FOLD: RCKT (25.6M) vs FOLD (445M). FOLD has higher revenues than RCKT: FOLD (494M) vs RCKT (0).
FOLDRCKTFOLD / RCKT
Capitalization2.93B1.23B238%
EBITDA-9.2M-247.25M4%
Gain YTD-30.937-61.42850%
P/E RatioN/AN/A-
Revenue494M0-
Total Cash250M236M106%
Total Debt445M25.6M1,738%
FUNDAMENTALS RATINGS
FOLD vs RCKT: Fundamental Ratings
FOLD
RCKT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
44
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
6091
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCKT's Valuation (44) in the Biotechnology industry is in the same range as FOLD (75). This means that RCKT’s stock grew similarly to FOLD’s over the last 12 months.

RCKT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as FOLD (100). This means that RCKT’s stock grew similarly to FOLD’s over the last 12 months.

RCKT's SMR Rating (97) in the Biotechnology industry is in the same range as FOLD (98). This means that RCKT’s stock grew similarly to FOLD’s over the last 12 months.

FOLD's Price Growth Rating (60) in the Biotechnology industry is in the same range as RCKT (91). This means that FOLD’s stock grew similarly to RCKT’s over the last 12 months.

FOLD's P/E Growth Rating (100) in the Biotechnology industry is in the same range as RCKT (100). This means that FOLD’s stock grew similarly to RCKT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FOLDRCKT
RSI
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
70%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 21 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
75%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
68%
Aroon
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
82%
View a ticker or compare two or three
Ad is loading...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
POPFX27.740.28
+1.02%
Prospector Opportunity
JLGAX20.220.18
+0.90%
JAG Large Cap Growth A
LSSIX30.390.18
+0.60%
Loomis Sayles Small Cap Growth Instl
CMNIX15.07N/A
N/A
Calamos Market Neutral Income I
SMFAX30.65-1.05
-3.31%
American Beacon Stephens Mid-Cap Gr A

FOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, FOLD has been loosely correlated with ALDX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if FOLD jumps, then ALDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FOLD
1D Price
Change %
FOLD100%
+0.72%
ALDX - FOLD
46%
Loosely correlated
+0.41%
VCYT - FOLD
43%
Loosely correlated
+4.66%
RCKT - FOLD
42%
Loosely correlated
+1.85%
SRPT - FOLD
42%
Loosely correlated
-0.42%
DNLI - FOLD
41%
Loosely correlated
-0.19%
More